Temazepam and Panniculitis - a phase IV clinical study of FDA data

Summary:

Panniculitis is reported as a side effect among people who take Temazepam (temazepam), especially for people who are female, 60+ old, also take Etoposide, and have Small cell lung cancer extensive stage.

The phase IV clinical study analyzes which people have Panniculitis when taking Temazepam. It is created by eHealthMe based on reports of 40,724 people who have side effects when taking Temazepam from the FDA, and is updated regularly.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

What is Panniculitis?

Panniculitis (inflammation of the subcutaneous fat) is found to be associated with 282 drugs and 404 conditions by eHealthMe. Check the latest studies of Panniculitis.

On Jul, 05, 2026

40,724 people reported to have side effects when taking Temazepam.
Among them, 11 people (0.03%) have Panniculitis.

Among these 11 people:

What is the gender of people who have Panniculitis when taking Temazepam? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Panniculitis when taking Temazepam? *

What are other drugs people take besides Temazepam? *

Carboplatin: 8 people, 72.73%
Esomeprazole Magnesium: 8 people, 72.73%
Etoposide: 8 people, 72.73%
Acetaminophen: 7 people, 63.64%
Omeprazole: 7 people, 63.64%
Ondansetron: 6 people, 54.55%
Sodium Chloride: 5 people, 45.45%
Clemastine Fumarate: 4 people, 36.36%
Singulair: 2 people, 18.18%
Ipratropium Bromide: 2 people, 18.18%

What are other side effects people have besides Panniculitis? *

Pneumonia: 6 people, 54.55%
Gastrointestinal Pain: 4 people, 36.36%
Headache (pain in head): 4 people, 36.36%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 18.18%
Drug Toxicity: 1 person, 9.09%
Fainting (loss of consciousness and postural tone): 1 person, 9.09%
Erythrocyte Sedimentation Rate Increased: 1 person, 9.09%
Emotional Disorder: 1 person, 9.09%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 1 person, 9.09%
Death: 1 person, 9.09%

What are the existing conditions these people have? *

Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 5 people, 45.45%
Small Cell Lung Cancer Metastatic (lung cancer spreads to other body parts): 3 people, 27.27%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and have Panniculitis?

- Check whether Panniculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temazepam:

Temazepam (42,106 reports)

Panniculitis treatments and more:

Panniculitis (3,420 reports)

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panniculitis:

Panniculitis (282 drugs)

Browse all the conditions that are associated with Panniculitis:

Panniculitis (404 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temazepam) and Temazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.